Genetic defects in SAPK signalling, chromatin regulation, vesicle transport and CoA-related lipid metabolism are rescued by rapamycin in fission yeast by Kenichi Sajiki et al.
Genetic defects in SAPK signalling, chromatin
regulation, vesicle transport and CoA-related
lipid metabolism are rescued by rapamycin in
fission yeast
Author Kenichi Sajiki, Yuria Tahara, Alejandro
Villar-Briones, Tomas Pluskal, Takayuki
Teruya, Ayaka Mori, Mitsuko Hatanaka, Masahiro
Ebe, Takahiro Nakamura, Keita Aoki, Yukinobu
Nakaseko, Mitsuhiro Yanagida
journal or
publication title
Open Biology
volume 8
page range 170261
year 2018-03-28
Publisher The Royal Society
Rights (C) 2018 The Author(s).
Author's flagpublisher
URL http://id.nii.ac.jp/1394/00000612/
doi: info:doi/10.1098/rsob.170261
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/
http://rsob.royalsocietypublishing.org/ on March 28, 2018
OPEN
BIOLOGY
rsob.royalsocietypublishing.org
Research a ®updates
Cite this article: Sajiki K et al. 2018
Genetic defects in 5APK signalling, chromatin
regulation, vesicle transport and CoA-related
lipid metabolism are rescued by rapamycin in
fission yeast. Open Biol. 8: 170261.
http://dx.doi.Org/10.1098/rsob.170261
Received: 8 December 2017
Accepted: 19 February 2018
Subject Area:
cellular biology
Keywords:
rapamycin, SAPK, fission yeast, mutant
screening, quantitative metabolomics
Authors for correspondence:
Kenichi Sajiki
e-mail: sajiki@oist.jp
Mitsuhiro Yanagida
e-mail: myanagid@gmail.com
Present address: Whitehead Institute for
Biomedical Research, 455 Main Street,
Cambridge, MA, USA.
ネPresent address: The University of Tokyo,
Komaba Campus l; Build. 15, 3-8-1 Komaba,
Meguro-ku, Tokyo 153-8902, Japan.
§Present address: Microbial Genetics
Laboratory, Genetics Strains Research Center,
National Institute of Genetics, 1111 Yata,
Mishima, Shizuoka 411-8540, Japan.
Electronic supplementary material is available
online at https://dx.doi.org/10.6084/m9.
figshare.c.4028185.
THE ROYAL SOCIETY
Genetic defects in SAPK signalling,
chromatin regulation, vesicle transport
and CoA-related lipid metabolism are
rescued by rapamycin in fission yeast
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Takayuki Teruya1, Ayaka Mori1, Mitsuko Hatanaka1, Masahiro Ebe1,
Takahiro Nakamura1，*, Keita Aoki2'§, Yukinobu Nakaseko2
and Mitsuhiro Yanagida1
' Okinawa Institute of Science and Technology Graduate University, 1919-1 Tancha, Onna-son,
Okinawa 904-0495, Japan
Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan
KS, 〇〇〇〇-〇〇〇1-7886-2979
Rapamycin inhibits TOR (target of rapamycin) kinase, and is being used clini-
cally to treat various diseases ranging from cancers to fibrodysplasia ossificans
progressiva. To understand rapamycin mechanisms of action more compre-
hensively, 1014 temperature-sensitive (ts) fission yeast ( Schizosaccharomi/ces
pombe ) mutants were screened in order to isolate strains in which the ts pheno-
type was rescued by rapamycin. Rapamycin-rescued 45 strains, among
which 12 genes responsible for temperature sensitivity were identified.
These genes are involved in stress-activated protein kinase (SAPK) signalling,
chromatin regulation, vesicle transport, and CoA- and mevalonate-related
lipid metabolism. Subsequent metabolome analyses revealed that rapamycin
upregulated stress-responsive metabolites,while it downregulated purine bio-
synthesis intermediates and nucleotide derivatives. Rapamycin alleviated
abnormalities in cell growth and cell division caused by styl mutants (Ash/2 )
of SAPK. Notably, in Asti/1, rapamycin reduced greater than 75% of over-
produced metabolites (greater than 2x WT), like purine biosynthesis
intermediates and nucleotide derivatives, to WT levels. This suggests that
these compounds may be the points at which the SAPK/TOR balance regu-
lates continuous cell proliferation. Rapamycin might be therapeutically
useful for specific defects of these gene functions.
1. Introduction
Rapamycin is an antifungal metabolite discovered in the 1970s in Streptomycin
hygroscopicus. It inhibits cell proliferation and antibody formation by T cells,
which prompted its use as an immunosuppressive drug for organ transplantation
(known by the generic nameSirolimus) [1]. Rapamycin formsa complex with pep-
tidyl-prolyl-isomerase, FKBP12, to inhibit serine/ threonine protein kinases
designated TOR (target of rapamycin) [2-5]. TOR kinases comprise two distinct
protein complexes inside cells that regulate cell proliferation [6]. Various studies
have shown that many TOR pathway components are associated with cancer
[7-10], and as a result, rapamycin has been used as an anti-tumour drug. Clinical
trials have confirmed its effectiveness against mammary tumours, colon cancer,
melanocarcinoma and ependymoblastoma [11]. In addition, rapamycin also
extends the lifespans of yeast,fruit fliesand mice [12-15], probably by reducing cal-
orieconsumption.Recently, rapamycin becamethe first drugin clinical trials for the
treatment of fibrodysplasia ossificans progressiva, using patient-derived induced
© 2018 The Authors. Published by the Royal Society under the terms of the Creative Commons Attribution
License http://creativecommons.0rg/licenses/by/4.0/, which permits unrestricted use, provided the original
author and source are credited.
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Figure 1. Screening of 1014 temperature-sensitive mutants yielded 45 strains in which the ts phenotype was rescued by rapamycin. (a) Spot tests of WT (h— 972),
parental strain [ leu1-32 arp8-GFP), the previously reported cut1-21 strain, on YPD plates with 0.1 |xg ml — 1 rapamycin at 36 C clearly showed the rescue effect.
(b) Schematized procedures of bulk screening using 96-well plates.
pluripotent stem cells [16]. Most recently, rapamycin has also
proved effective in treating Pompe disease,which causes lysoso-
mal glycogen accumulation in skeletal muscle and heart [17].
The fission yeast Scnizosaccharomyces pombe has proved to
be an excellent model for studying cellular functions of rapa-
mycin and the TOR pathway, owing to the availability of
genetic methods, comprehensive mutant libraries and high
conservation of mammalian TOR pathway components [18].
In our previous report, we discovered that temperature sensi-
tivity (ts) of cutl /separase and cut2 / securin mutants was
rescued by rapamycin, illuminating a new aspect of TOR
signalling in cell growth and division [19]. This discovery
suggested that there still exist undiscovered ts mutants
that could offer a more comprehensive understanding of
rapamycin. Accordingly, in the hope of discovering novel
applications of this drug, we tested the capability of rapamycin
to rescue mutants in our ts mutant library, which contains 1014
strains [20]. Mutants defective in 12 genes were found to be res-
cued by rapamycin. Among them, styl mutants were further
studied to show that rapamycin alleviated abnormal growth
and division of these mutants. Also, we report a metabolome
analysis to reveal the cellular impact of rapamycin. Metabolo-
mic results strongly suggested that purine biosynthesis is
implicated in the critical regulation targeted by rapamycin.
2. Results
2.1. Screening of the ts mutant library for
rapamycin rescue
For library screening, a pilot spot test using a control strain (cutl -
21 ) [19] showed that a rapamycin concentration of 0.1 jxg ml — 1
was useful ( figure la ), because higher concentrations (e.g.
greater than 1|xg ml" l) inhibited growth of the parental strain
of this library ( lenl -32 arp8-GFP ) at the restrictive temperature
(36 C). Therefore, using an automated robot system, screen-
ing was conducted by spotting 1014 ts mutants [20] onto
YPD plates with or without 0.1 \xg ml 1 rapamycin
(figure lb). At 36 C, 62 strains showed better colony formation
on YPD plates with rapamycin than without (electronic
supplementary material, figure SI). These strains were further
tested by serial dilution and manual spotting on plates to elim-
inate false positives (electronic supplementary material, figure
S2). In 45 strains, it was confirmed that rapamycin rescued the
ts phenotypes (figure 2a ). Then, the mutated genes responsible
for ts sensitivity were identified by suppression analysis and by
either tetrad analysis or whole-genome sequencing (electronic
supplementary material, table SI, Material and methods).
2.2. Rapamycin-rescued ts phenotypes of mutations
in 12 genes
Among these 45 strains, 12 genes proved responsible for the
ts phenotype (electronic supplementary material, table SI).
They must be sole responsible genes for each strain,
because plasmids containing WT genes for other background
mutations could not rescue the ts phenotype. Based on reported
functions, they belonged to four categories (figure 2b): stress-
activated protein kinases (SAPK) (two genes), chromatin
regulation (three genes), transport (four genes) and lipid
metabolism (three genes).
The largest number of strains involved either of two SAPK
mutants, styl (MAPK; five strains) and zvisl (MAPKK; five
strains) ( figure 2n ).These genes are central to the stress-respon-
sive signalling pathway, and Wisl phosphorylatesStyl [21,22].
Mutations in all sti/ 1 and wisl strains with amino acid substi-
tutions were located in or near their protein kinase domains,
and all with nonsense mutations ( sty1-791, zvisl -887, styl -989 )
lacked the C-terminal half of the kinase domains (electronic
supplementary material, table SI), uiven their abundance,
we examined these mutants further.
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Figure 2. Twelve genes were responsible for the ts phenotypes of strains identified as responsive to rapamycin. ( a) Spot tests of 45 strains on YPD or YPD
rapamycin (Rap) plates at 36 C. Names of responsible genes are in parentheses next to strain numbers. (W The 12 responsible genes were classified into four groups,
based on their reported cellular functions.
In the chromatin regulation gene group, one cut! mutant
(cutl -109 ) was identified in addition to the previously reported
cutl -21 [19】. Cutl cleaves Rad21, which is a subunit of cohesin
complex. It should be noted that 18 other cutl mutants exist in
this library, so further spot tests were performed for them. In
fact,most of them revealed a more temperature-sensitive pheno-
type, which was also rescued by rapamycin (electronic
supplementary material, figure S3A). Mutation sites were con-
centrated in Cutl’s peptidase and central domains (electronic
supplementary material, figure S3B). Other chromatin regu-
lation genes included mis4, a cohesion loader for establishing
sister chromatid cohesion [23,24], and htbJ , a histone H2B
(figure 2c). Four other htbl mutants have been identified in this
library. Of those, two were mutated at the N-terminus: htbl -
377 (G30D) and htbl -442 (E35 K) and showed the rescue pheno-
type, while htbl-72 (G52D) and htbl -223 (PI02 L) did not [25】.
The N-terminal end of H2B is phosphorylated under stressful
conditions [26,27], suggesting the basis for this allelic difference.
In the vesicle transport gene group, one clathrin-binding
gene ( ucp7 ), one exocytic Rab-type GTPase gene ( i/ pt2 ) and
its GTP exchange factor ( sec2 ), and one Rab geranylgeranyl
transferase-related gene (mrs6) were identified (figure 2b ).
In the metabolism gene group, there were three genes
related to CoA metabolism and the mevalonate pathway:
erglO (acetyl-CoA C-acetyltransferase), ceml (3-oxoacyl-
[acyl-carrier-protein]-synthase condensing enzyme) and fpsl
( famesyl diphosphate synthase) ( figure 2b ).
2.3. Rapamycin-induced cell aivision at 36 L, in
contrast to SAPK mutations
All SAPK ts mutants showed identical phenotypes, and
we also found a deletion strain of styl (^styl ) that was
similar. As with ts mutants, the Ash/1 strain showed reduced
viability at 36 C, which was rescued by rapamycin
(figure 3d ). Therefore, Astyi was used to study functional
implications of SAPK and rapamycin, in order to eliminate
potential dominant negative effects of ts mutants.
At the permissive temperature, 26 C,とstyl cells multiply
slightly more slowly than WT, displaying longer cell lengths
(figure 3a,b,e ). At 26 C, addition of 200 nM rapamycin did
not have a significant effect upon the rate of cell division, a
negative result reported previously [28]. At 36 C, Astyl
showed a ts phenotype with retarded mitotic increase, while
WT cells divided much more rapidly ( figure 3a,b ). At tms
temperature, rapamycin rescued the ts phenotype of Asti/ 1,
accelerating cell division approximately 1.63-fold (figure 3^).Similar effects were also observed in the ts strain, styl-989
(electronic supplementary material, figure S4).
2.4. Rapamycin-rescued nuclear abnormality and
viability loss of the SAPK mutant, Astyl , at 36 C,
even under nitrogen deprivation
Cell morphology of Astyl was further examined at 36 C. Six
hours after the temperature shift, cell size was abnormally
elongated and septated cells were frequently observed
(figure 3e). Also, nuclei appeared enlarged and deformed in
Ash/2. Such deformation was moderated by rapamycin. In fact,
subsequent FACS analysis of Ash/2 showed that its 2C DNA
peak expanded to the right at 36 C, but this expansion was alle-
viated when rapamycin was added ( figure 3/ ). Thus, Styl and
rapamycin may maintain proper nuclear and cell shapesat36 C.
Previously, we reported that SAPK mutants showed abnor-
mally expanded nuclei and severely decreased viability after
nitrogen deprivation (-N) [29], so we tested whether rapamy-
cin could also rescue this phenotype. After — N, WT cells
undergo two divisions without cell growth, resulting in a
roughly fourfold increase in cell number. GO phase cells are
small and round, and most have 1し DNA content
(figure 3g,i,j ). They complete GO phase entry within 24 h after
— N, and maintain high viability ( figure 3//). However, Astyl
•••參 rsob.royalsocietypublishina
.org
0pen
BbL
S
:
170261
V.V
f
Downloaded from http://rsob.royalsocietypublishing.org/ on March 28, 2018
(a ) cell number (fold change) (c) viability (Oh as 100%)
2
100
5()
0
Oh lh 2h 3 h 4 h 5 h 6h Oh 2 h 4 h 6h 8 h 24 h
26°C,-Rap
26°C, +Rap
36°C,-Rap
36°C, +Rap
( b ) i d )
5
I 3
2
1
100
50
0
Oh lh 2 h 3 h 4 h 5h 6h Oh 2 h 4 h 6h 8 h 24 h
( e ) 26°c (0 h) ^— ^ ^— ^ ⑺卜
_
k 11\\\M\\
、〃 七場mmmmn 響:士 ir
2C 2C
(g) cell number (fold change) (/? )
5 ■ 0 h ■ 24 h 120
viability (0 h as 100%) (0 -N 24 h-Rap +Rap U )
4
3
2
0
WT
Kl
g
I
吊•
•a
テ
f
J
§
§
00
'■'■J
NJo>
Ast} /
_
N
24 h
+Rap
-Rap
+N 0 h
-Rap +Rap -Rap +Rap
WT Aslyl
-Rap +Rap -Rap +Rap 1IC 2C 1C 2C
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mutant cells could not stop cell growth or division after — N,
increasing in number by about 4.3-fold. Cells were elongated
with 2C DNA content (figure 3g,i,j ). This demonstrates a
clear failure of GO phase entry, and cells lost all viability 24 h
after — N (figure 3h), as with ts mutants reported previously
[29]. When rapamycin was added to Ash/ 1, however, cell
number increment after — N was suppressed to the WT level,
and viability recovered by 39% (figure 3g,h ). Interestingly, this
rescue occurred without rescuing the elongated cell shape
and 2C DNA content ( figure 3i,j ), implying cell morphology
and viability are separately regulated under 一N.
2.5. Rapamycin induces stress-responsive metabolites
and basic amino acid derivatives at 36 C
In order to examine effects on metabolism induced by rapamy-
cin, we conducted quantitative metabolomic analysis of WT
and Ash/2 cell cultures incubated for 6 h at 3b C with or without
200 nM rapamycin, the smallest concentration able to inhibit
TOR signalling [28] (figure Aa ). Since cell size varied among
strains and conditions, data were normalized by protein
concentration (electronic supplementary material, table S2).
The experiment was run in triplicate and reproducibility was
confirmed using principal components analysis (figure 4b ).
In WT,compared with DMSO (the solvent used for rapamy-
cin, as a control), rapamycin increased nine metabolites greater
than twofold (figure 4c).Those metaboliteswere trehalose,basic
amino acids and their acetylated forms (arginine, histidine,
lysine, N-acetyl-arginme, N-acetyl-lysine, 4-guanidinobutano-
ate, ornithine), and glyceraldehyde-3-phosphate. Trehalose,
which showed the greatest increase, is well known as a stress-
responsive metabolite [30]. Interestingly, it was also signifi-
cantly induced in WT by rapamycin addition, but in Asti/7 ,
the trehalose level was already high before rapamycin addition
( figure 4d ), implying that Styl might control stress response
before adding rapamycin. WT and Ash/2 both increased basic
amino acid titres after rapamycin addition (figure 4c1 ).
2.6. Rapamycin reduces purine biosynthetic
intermediates, nucleotide derivatives and CoA
related metabolites at 36 C
In WT, rapamycin caused 13 metabolites to decrease to less
than half ( figure 4e ). The majority of these were purine
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Figure 4. Metabolome analysis revealed the cellular impact of rapamycin in WT and As^/. ( a) Schematized procedures of metabolome analysis, (b) Principal com-ponents analysis (PCA) was conducted for the entire dataset of 98 metabolites (electronic supplementary material, table S2). A scatter plot of scores of the two principal
components was shown, (c) List of metabolites that increased greater than twofold in a WT sample with rapamycin (Rap) compared with a control DMSO sample
(DMSO). The DMSO and Rap columns show normalized peak areas and Rap/DMSO column shows the fold change, ( d ) Normalized mean peak areas with standard
deviations of trehalose and basic amino acids in WT and My1 with DMSO or Rap. ( e ) List of metabolites that decreased more than 50% in a WT sample with Rap
compared with DMSO. ( f ) Normalized mean peak areas with standard deviations of acetyl-CoA and HMG-CoA in WT and Asty l with DMSO or Rap.
biosynthesis intermediates (FGAM, FGAR, PRPP) and nucleo-
tide-related metabolites (cytidine, mimethyl-guanosine,
JV-methylguanosine, CDP-choline). They accounted for
more than half of the decreased metabolites, implying that
nucleotide metabolism is a major target of rapamycin.
Beside nucleotide derivatives, HMG-CoA and acetyl-CoA
decreased by 78% and 51%, respectively ( figure 4/ ). As men-
tioned above, another major group of mutants rescued by
rapamycin is involved in CoA metabolism (figure 2b ). Inhi-
bition of the CoA pathway by rapamycin may be the basis
for rescuing such mutants.
2.7. In the SAPK mutant, Astyl , rapamycin abolished
overproduction of purine biosynthesis
intermediates and nucleotide derivatives
Metabolomic results indicated that many metabolites were over-
produced in Ash/2 cells. In those cells,37 metabolites were found
at concentrations greater than twofold the level seen in WT cells
(figure 5a, DMSO; electronic supplementary material, table S2).
However, with rapamycin addition, most of these overproduced
metabolites returned to WT levels, and only11 remained greater
than twofold (figure 5a,Rap;electronic supplementary material,
table S2). Among those adjusted to WT level by rapamycin,
those that decreased more than 50% included biosynthesis
intermediates (FGAM, SAICAR; figure 5c) and nucleotide
derivatives (CDP, CDP-choline, CDP-ethanolamine, CTP,
GDP, GDP-glucose, GTP, UTP; figure 5め. This implies that
purine Diosynthesis and nucleotide metabolism might be key
regulatory targets of SAPK and rapamycin.
On the other hand, only three metabolites in Astyl
decreased to less than 50% of the WT (figure 5b, DMSO;
electronic supplementary material, table S2). Those were
ergothioneine and methylated histidines, which could be
related to stress response. When rapamycin was added, three
more metabolites in Astyl decreased to less than 50% of the
WT (figure 5b, Rap; electronic supplementary material, table
S2). Again, two were purine biosynthesis intermediates
(AICAR, FGAR), further suggesting that the purine pathway
could be rapamycin’s physiological target.
3. Discussion
In this study, we identified mutants in which the ts pheno-
type was rescued by rapamycin. Although roles of TOR
have been reported in diverse cellular processes from protein
synthesis to autophagy [6】，the 12 genes identified here were
rather narrowly focused.
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Figure 5. Rapamycin abolished the overproduction of most metabolites in Astyl . ( a ) Venn diagram of metabolites that increased greater than twofold in AstyJ
compared with WT with DMSO or Rap. In the presence of rapamycin, metabolites (in red) decreased to less than 50% of their values when AstyJ was cultured in
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for maintaining the appropriate balance.
The most abundant were SAPK mutants, wisl and styl ,
each comprising five ts alleles. Four wisl and three styl
mutants involved single amino add substitutions. Further, all
but one ( ivisl -982 ) of these seven missense mutations occurred
at conserved amino acids in the catalytic domains of Wisl
and Styl, strongly suggesting that the loss of function for
these protein kinases might be compensated by rapamycin-
dependent inactivation of TOR signalling. Thus, the TOR and
SAPK signalling pathways seem most likely to have opposing
principal cellular functions.
The most striking aspect of suppression of the SAPK Ash/2
mutant by rapamycin is that cell viability is restored in both
+N and — N media when rapamycin is added (figure 3d,h ),
whereas the abnormal rod-like shape of Asfi/2 cells remains
in — N media (figure 3/ ). Furthermore, the DNA content of
Ash/2 in — N media remains 2C (figure 5j ), indicating that
rapamycin cannot restore GO phase quiescent cell shape and
DNA content. It is thus critically important to determine the
rapamycin target for restoring cell viability.
The mechanism of rescue required further investigation.
One possibility was suggested by our metabolome analysis,
showing that overproduction of purine biosynthesis inter-
mediates and nucleotide derivatives in Astyl was abolished
by rapamycin. In excess, these metabolites in Ash/2 cells
might cause cell death. Rapamycin especially reduced the
level of purine intermediates, like FGAM. In support of
such a conclusion, mTORCl was recently reported to be
linked to de novo purine synthesis via the mitochondrial
tetrahydrofolate cycle [31]. These are just our initial findings
for complex regulation between SAPK and TORC, and we
would like to continue more detailed metabolome analyses
in future to reveal the mechanisms.
In addition to SAPK, we also identified chromatin regu-
lation, vesicle transport and CoA metabolism genes from
rapamycin screening. The chromatin regulation group com-
prised three genes rescued by rapamycin. Among them, Cutl
and Mis4 are for cohesin release and loading of chromatin,
respectively [23,24,32,33], while Htbl is for nucleosomal his-
tone H2B function [25]. Previously, a possible explanation for
the rescue of cutl mutants by rapamycin was thought to be
that the crucial balance between TORC1 and Cutl /separase
might prevent premature sister chromatid separation, in
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which low TORC1 activity alleviates theCutl requirement [19].
However, it may be that in these mutants, the delicate balance
between cell elongation and cell division is modulated by rapa-
mycin through its influence over TORし signalling responding
to nutritional cues.
The vesicle transport group comprised four genes. Regu-
lation of endosome maturation and endocytosis/exocytosis
by TOR signalling and /or rapamycin has been reported
[34-38], so some strains rescued by inhibiting the TOR
pathway may involve tms mechanism.
The metabolism group was related to lipid metabolism and
CoA regulation, comprising three genes, ErglO, Fpsl and
Ceml. ErglO catalyses reactions between acetyl-CoA and
acetoacetyl-CoA [39]. Both are substrates for the mevalonate
pathway to produce geranyl diphosphates for prenylation of
Rlieb and Rab GTPases [40-42] (figure 2c). Lipids are required
for homeostatic synthesis of new membranes during GO quies-
cence. TOR signalling is reported to activate the mevalonate
pathway via the sterol-responsive element-binding protein
(SREBP) [43,44]. Notably, because mrs6 (Rab geranylgeranyl
transferase) was also identified in addition to fpsl , these metab-
olism genes could contribute to prenylation of vesicle transport
proteins. Ceml is a beta-keto-acyl synthase that directs
the use of acetyl-CoA in fatty acid biosynthesis [45]. These
metabolism genes may also work to balance synthesis and
degradation of lipids.
Previously, large-scale screening of yeast deletion libraries
has been conducted to test rapamycin sensitivity [46,47].
Genes affecting rapamycin sensitivity are mainly involved in
upregulation of TOR signalling, as gene deletions cause hyper-
sensitivity to rapamycin. By contrast, our screening employed
a ts mutant library in which cell proliferation is disrupted at the
restrictive temperature, but is rescued by rapamycin. Rapamy-
cin actions apparently compensate for these deletions and ts
mutants. Genes identified in the present study seem to be
required to balance TOR signalling for continuous cell prolifer-
ation (figure 5e) and raise the possibility of therapeutic
applications for rapamycin. Notably, human orthologues of
ErglO, Mis4 and Mrs6 are reportedly associated with beta-
ketotliiolase denciency, Cornelia de Lange syndrome and
intellectual disability, respectively [48-50]. In addition,
Cut2/PTTG, a regulator of Cutl/ESPLl, is reportedly associ-
ated with cancer [51], while the SAPK cascade is a key
therapeutic target of inflammatory disease [52,53]. Our results
suggest the potential use of rapamycin to cure or ameliorate
these diseases resulting from these genes.
4. Material and methods
4.1. Strains
A collection of 1014 ts mutant strains made by random muta-
genesis was used [20]. To identify the mutation responsible
for the phenotype, first, a plasmid set containing fragments
of an S . pombe genomic library was introduced to each strain.
Plasmids that rescued the ts phenotype were sequenced to
identify suppressor genes. Second, if suppressor genes were
definitive, tetrad analysis was conducted to identify the
responsible gene. Or if several suppressor genes were ident-
ified, whole-genome sequencing was employed as follows.
Mutant strains were backcrossed with WT to collect segregants
showing the ts phenotype (ts ). DNA samples from several ts-
segregants were extracted, mixed equally and sequenced using
a Genome Analyzer IIx sequencer (Illumina). Background
mutations were eliminated and mutations common to all ts
segregants, which were also identified previously among sup-
pressor plasmids, were confirmed as the responsible genes.The
other strain used in this study was h Asti/ l ::ura41 ura4-D18
(KS1366) [21] for the Astyl study.
4.2. Screening method and spot test assays
Rough screening of all 1014 strains was conducted using an
automated robot system (Biomek FX, Beckman Coulter).
Cells were cultivated in YPD liquid media and adjusted to a
concentration of 1 x 106 cells m l 1, after which 3|xl were
spotted on YPD agar plates with or without 0.1 (xg ml — 1 rapa-
mycin (figure la). Plates were incubated at 36 C for 3days, and
colony formation was compared. Subsequent manual spot
tests were conducted by cultivating cells to 1 x 107 cells ml — 1
and serially diluting them in five steps (10-fold dilution in
each step). Then 5 (xlof each dilution were spotted on new
plates. Spotted plates were incubated at 36 C.
4.3. Nitrogen deprivation, cell number, viability assays
and flow cytometry
Nitrogen deprivation was accomplished by switching the cul-
ture media of exponentially growing cells from EMM2 to
EMM2-N (EMM2-N lacks NH4C1) by vacuum filtration, as
described previously [54]. Cell number was measured using a
Mulnsizer3 coulter counter (Beckman Coulter), and cell
viaoility was measured by plating 300 cells on YPD plates and
determining the percentage of the number of colonies formed
per plated cell. To measure the DNA content, FACS analysis
was conducted using a FALSCalibur (Becton Dickinson).
4.4. Microscopy
For DAPI staining, cells were fixed with 270 glutaraldehyde
for 10 min on ice, washed 3x with phosphate-buffered
saline (PBS), and observed under a fluorescence microscope
(Axioplan2, ZEISS) after mixing with DAPI (25 fxg ml- ' ).
35
0
l
•a
テ
M
0
ぶ
嘗
〇〇
KJ
4.5. Metabolome analysis
WT and Astyl samples in liquid EMM2 with DMSO or 200 nM
rapamycin were incubated for 6 h at 36 C and 40 ml of 5 x
10b cells ml — 1 were harvested. Metabolome samples were pre-
pared as described previously [55,56] and protein amount for
each sample was measured using Direct Detect (Merck).
Samples were spiked with two internal standards, PIPES and
HEPES, corrected for protein quantity, extracted and separated
by liquid chromatography on a ZIC-pHILIC column (Merck),
and then measured using an LTQ〇rbitrap mass spectrometer
(Thermo Fisher Scientific). MZMINE2 software was used for raw
mass spectrum analysis [57]. From areas of detected peaks,
principal components analyses were calculated and the two
principal components were plotted using SIMCA P+ software
(Sartorius Stedim) to show clear differentiation of the
triplicates under each condition (figure 4b ).
Among detected peaks, 95 metabolites were identified by
comparing m/z values and retention times with authentic
standards. Additionally, FGAM, FGAR and SAICAR were
identified as previously explained [56].
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